What is NDC 84677-081?

84677-081 is the product NDC for Tofacitinib Citrate, Tofacitinib citrate 11 mg/1 tablet, film coated, extended release, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Golden State Medical Supply, Inc., NDC labeler code 84677. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tofacitinib Citrate?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tofacitinib Citrate NDC 84677-081 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)84677-081Labeler and product segments. Claims need a package NDC.

Product NDC at billing width84677-0081Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
84677-081-30	8467700813084677008130	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84677-081-30)Marketed from Sep 9, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tofacitinib Citrate
Generic name (nonproprietary): tofacitinib citrate
Active ingredients: Tofacitinib citrate — 11 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Golden State Medical Supply, Inc.NDC labeler code 84677
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220972
Marketing start: Jun 25, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Janus Kinase Inhibitors (Mechanism)
Identifiers: Product ID 84677-081_5dd4349f-edf9-2aec-e063-6394a90ab7a0SPL ID 5dd4349f-edf9-2aec-e063-6394a90ab7a0
Pharmacologic class: Janus Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N484677008130 followed by a unit qualifier and the quantity

Package 84677-0081-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 84677-081

What is NDC 84677-081?: 84677-081 is the product NDC for Tofacitinib Citrate, Tofacitinib citrate 11 mg/1 tablet, film coated, extended release, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tofacitinib Citrate.
What is the active ingredient?: Tofacitinib citrate.
Who is the labeler?: Golden State Medical Supply, Inc., NDC labeler code 84677. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tofacitinib Citrate?: 4 other product NDCs are listed under this name. See all Tofacitinib Citrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tofacitinib Citrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tofacitinib Citrate	Tofacitinib citrate 8.08 mg/1	Tablet, Film coatedOral	Stellon Biotech Inc.	85972-121	85972-0121-60
Tofacitinib Citrate	Tofacitinib citrate 16.16 mg/1	Tablet, Film coatedOral	Stellon Biotech Inc.	85972-122	85972-0122-60
Tofacitinib Citrate	Tofacitinib citrate 11 mg/1	Tablet, Film coated, Extended releaseOral	ScieGen Pharmaceuticals, INC.	50228-567	50228-0567-1050228-0567-30
Tofacitinib Citrate	Tofacitinib citrate 11 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc.	77771-567	77771-0567-30
Tofacitinib Citrate	Tofacitinib citrate 11 mg/1	Tablet, Film coated, Extended releaseOral	Padagis US LLC	0574-1811	00574-1811-30

Other NDCs under ANDA 220972

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220972
Product	Strength	Form · route	Labeler	Product NDC
Tofacitinib Citrate	Tofacitinib citrate 11 mg/1	Tablet, Film coated, Extended releaseOral	ScieGen Pharmaceuticals, INC.	50228-567
Tofacitinib Citrate	Tofacitinib citrate 11 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc.	77771-567